A clinical study for adults with asthma

Image

For adults with Asthma

The AIRLYMPUS Study is testing an investigational study drug to see if it is safe and can possibly improve breathing and symptoms of asthma and potentially reduce future asthma attacks when taken with standard asthma background therapy.

Interested in learning more?

Your participation is voluntary. By participating, you could possibly contribute to the discovery of a potential future new treatment for people like you who have asthma.

Contact us to complete the survey and find out in minutes if you're qualified. (281) 377-3988 or houston@axsendoclinical.com

Living with Asthma

Do you have difficulty breathing?

Asthma can cause shortness of breath and wheezing that limits your ability to keep up with work, family, and friends.

Does the fatigue impact regular activity?

Asthma can also lead to fatigue and low energy, making it harder to engage in normal daily activities.

Is Asthma holding you back?

Whether it’s missing out on social activities, avoiding physical exercise, struggling to keep up at work or school, or constantly worrying about when the next flare-up will strike, asthma can quietly limit the freedom to live life to the fullest.

This clinical study is being offered in our Houston, Texas market and is investigating a potential treatment that may help reduce some symptoms of asthma. To find out how you may be able to participate, click the button below.

Who is eligible?

If you qualify for the study, you will receive either the investigational study drug
or the placebo. Treatment, tests, and doctor visits at no cost to you.
You may be in the study for up to 64 weeks.

Adults between the ages of 18 and 80

Have had a diagnosis of asthma within the past 12 months

Have had at least 1 asthma attack in the last year and currently taking treatment for your daily asthma